US Stock MarketDetailed Quotes
SMMT Summit Therapeutics
- 13.080
- -0.440-3.25%
Close Aug 23 16:00 ET
- 13.590
- +0.510+3.90%
Pre 08:28 ET
9.48BMarket Cap-118909P/E (TTM)
14.250High12.940Low2.44MVolume13.640Open13.520Pre Close32.71MTurnover2.55%Turnover RatioLossP/E (Static)724.54MShares14.25052wk High48.62P/B1.25BFloat Cap1.52052wk Low--Dividend TTM95.90MShs Float19.750Historical High--Div YieldTTM9.69%Amplitude0.660Historical Low13.400Avg Price1Lot Size
About Summit Therapeutics Company
Summit Therapeutics Plc operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom.
Company Profile
SymbolSMMT
Company NameSummit Therapeutics
Listing DateMar 5, 2015
Founded2004
CEOMr. Robert W. Duggan
MarketNASDAQ
Employees105
Fiscal Year Ends12-31
Address136a Eastern Avenue,Milton Park
CityAbingdon
ProvinceOxfordshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeOX14 4SB
Phone44-1235-443939
Websitehttp://summitplc.com
Company Executives
- Name
- Position
- Salary
- Dr. Mahkam Zanganeh
- Executive Director,Co-Chief Executive Officer and President
- --
- Robert W. Duggan
- Executive Director,Chairman and Chief Executive Officer
- --
- Manmeet Singh Soni
- Non-Executive Director
- --
- Dr. Yu Xia
- Non-Executive Director
- --
- Ujwala Mahatme
- Non-Executive Director
- --
- Robert Booth
- Non-Executive Director
- --
- Dr. Alessandra Cesano, M.D.
- Non-Executive Director
- --
- Kenneth A. Clark
- Non-Executive Director,Lead Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg